Share on StockTwits

Magellan Health Services (NASDAQ:MGLN) CFO Jonathan N. Rubin unloaded 13,041 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $62.18, for a total value of $810,889.38. Following the sale, the chief financial officer now directly owns 16,382 shares of the company’s stock, valued at approximately $1,018,633. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Magellan Health Services (NASDAQ:MGLN) traded up 1.22% on Wednesday, hitting $63.06. 361,567 shares of the company’s stock traded hands. Magellan Health Services has a 52 week low of $53.01 and a 52 week high of $62.62. The stock’s 50-day moving average is $59.25 and its 200-day moving average is $58.93. The company has a market cap of $1.738 billion and a P/E ratio of 14.04.

Magellan Health Services (NASDAQ:MGLN) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.92 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.75 by $0.17. The company had revenue of $966.50 million for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter last year, the company posted $1.01 earnings per share. Magellan Health Services’s revenue was up 17.6% compared to the same quarter last year. On average, analysts predict that Magellan Health Services will post $2.40 earnings per share for the current fiscal year.

MGLN has been the subject of a number of recent research reports. Analysts at TheStreet upgraded shares of Magellan Health Services from a “hold” rating to a “buy” rating in a research note on Monday. Separately, analysts at Jefferies Group raised their price target on shares of Magellan Health Services from $56.00 to $58.00 in a research note on Wednesday, April 30th. They now have a “hold” rating on the stock. Finally, analysts at Ned Davis Research upgraded shares of Magellan Health Services from a “neutral” rating to a “buy” rating in a research note on Monday, April 21st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $60.82.

Magellan Health Services Inc, is engaged in the specialty managed healthcare business. The Company provides services to health plans, insurance companies, employers, labor unions and various governmental agencies.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.